Company intelligence / Profile preview

Soll Eye

Philadelphia, Pennsylvania, United Statescooperhealth.org ↗

Ownership: Private
Development stage: Other

Overview

Soll Eye was one of the top eye health providers in the Northeast US for over six decades, offering comprehensive ophthalmic care including primary eye care, cataract surgery, vitreo-retinal procedures, oculoplastics, and optical services. In January 2020 it was acquired by ReFocus Eye Health to expand their regional presence. The team included nationally recognized doctors delivering advanced surgical and medical treatments with access to cutting-edge technology post-acquisition.

Therapeutic areas: Ophthalmology
Modalities: Device (ophthalmic surgery)Non-pharmacological therapy (vision correction procedures)
Industry: Non-Academic Healthcare

Partnerships

Now part of ReFocus networkZenyth Partners (investment partner for parent company)

Beyond the preview

Go deeper on Soll Eye.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soll Eye.

Explore the full profile